In:
Pediatric Blood & Cancer, Wiley, Vol. 70, No. 2 ( 2023-02)
Kurzfassung:
Recent increased awareness and research studies reflect possible associations between opioid exposure and cancer outcomes. Children with neuroblastoma (NB) often require opioid treatment for pain. However, associations between tumor response to chemotherapy and opioid exposure have not been investigated in clinical settings. Methods This is a single‐institution retrospective review of patients with NB treated between 2013 and 2016. We evaluated opioid consumption quantified in morphine equivalent doses (mg/kg) based on nurse‐ or patient‐controlled analgesia during antibody infusions. We also analyzed their associations with change in primary tumor volume and total tumor burden. Results Of 42 patients given opioids for pain related to anti‐disialoganglioside monoclonal antibodies (anti‐GD2 mAb), data completion was achieved for 36, and details of statistical analyses were entered. Median total weight‐based morphine equivalent (over 8 days) was 4.71 mg/kg (interquartile range 3.49–7.96). We found a statistically insignificant weak negative relationship between total weight‐based morphine equivalents and tumor volume ratio (correlation coefficient −.0103, p ‐value .9525) and a statistically insignificant weak positive relationship between total weight‐based morphine equivalent and Curie score ratio (correlation coefficient .1096, p ‐value .5247). Conclusion Our study found no statistically significant correlation between opioid consumption and natural killer (NK) cell‐mediated killing of NB cells as measured by effects on tumor volume/tumor load.
Materialart:
Online-Ressource
ISSN:
1545-5009
,
1545-5017
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2023
ZDB Id:
2130978-4
